Ironing out Ferroportin

Cell Metabolism

Volumn 22, Issue 5, 2015, Pages 777-787

  Drakesmith, Hal ^a   Nemeth, Elizabeta ^b   Ganz, Tomas ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; FERROPORTIN; HEPCIDIN; IRON; CATION TRANSPORT PROTEIN; METAL TRANSPORTING PROTEIN 1;

ALZHEIMER DISEASE; DUODENUM; ENDOCYTOSIS; ERYTHROCYTE; ERYTHROPOIESIS; GENETIC DISORDER; HOMEOSTASIS; HOMOZYGOSITY; HOST RESISTANCE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION; IRON ABSORPTION; IRON DEFICIENCY; IRON HOMEOSTASIS; IRON KINETICS; IRON STORAGE; IRON TRANSPORT; LIVER CELL; MACROPHAGE; METABOLISM; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; UBIQUITINATION; ANIMAL; CHEMISTRY; GENETICS;

ANIMALS; CATION TRANSPORT PROTEINS; ERYTHROCYTES; ERYTHROPOIESIS; HEPATOCYTES; HEPCIDINS; HOMEOSTASIS; HUMANS; IRON; MACROPHAGES;

EID: 84948566965     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.09.006     Document Type: Review

References (111)

1. Abboud, S., and Haile, D. J. (2000). A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275, 19906-19912.
2. Altamura, S., Galy, B., Kessler, R., Hentze, M. W., and Muckenthaler, M. U. (2011). Mouse models for ferroportin with impaired hepcidin regulation. Am. J. Hematol. 86, E42.
3. Altamura, S., Kessler, R., Gröne, H. J., Gretz, N., Hentze, M. W., Galy, B., and Muckenthaler, M. U. (2014). Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload. Cell Metab. 20, 359-367.
4. Anderson, E. R., Taylor, M., Xue, X., Ramakrishnan, S. K., Martin, A., Xie, L., Bredell, B. X., Gardenghi, S., Rivella, S., and Shah, Y. M. (2013). Intestinal HIF2a promotes tissue-iron accumulation in disorders of iron overload with anemia. Proc. Natl. Acad. Sci. USA 110, E4922-E4930.
5. Arezes, J., Jung, G., Gabayan, V., Valore, E., Ruchala, P., Gulig, P. A., Ganz, T., Nemeth, E., and Bulut, Y. (2015). Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17, 47-57.
6. Ben-Othman, R., Flannery, A. R., Miguel, D. C., Ward, D. M., Kaplan, J., and Andrews, N. W. (2014). Leishmania-mediated inhibition of iron export promotes parasite replication in macrophages. PLoS Pathog. 10, e1003901.
7. Brown, D. E., Nick, H. J., McCoy, M. W., Moreland, S. M., Stepanek, A. M., Benik, R., O'Connell, K. E., Pilonieta, M. C., Nagy, T. A., and Detweiler, C. S. (2015). Increased ferroportin-1 expression and rapid splenic iron loss occur with anemia caused by Salmonella enterica Serovar Typhimurium infection in mice. Infect. Immun. 83, 2290-2299.
8. Callebaut, I., Joubrel, R., Pissard, S., Kannengiesser, C., Gérolami, V., Ged, C., Cadet, E., Cartault, F., Ka, C., Gourlaouen, I., et al. (2014). Comprehensive functional annotation of 18 missense mutations found in suspected hemochromatosis type 4 patients. Hum. Mol. Genet. 23, 4479-4490.
9. Canonne-Hergaux, F., Donovan, A., Delaby, C., Wang, H. J., and Gros, P. (2006). Comparative studies of duodenal and macrophage ferroportin proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G156-G163.
10. Chaston, T., Chung, B., Mascarenhas, M., Marks, J., Patel, B., Srai, S. K., and Sharp, P. (2008). Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut 57, 374-382.
11. Chen, H., Attieh, Z. K., Syed, B. A., Kuo, Y. M., Stevens, V., Fuqua, B. K., Andersen, H. S., Naylor, C. E., Evans, R. W., Gambling, L., et al. (2010). Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells. J. Nutr. 140, 1728-1735.
12. Cherukuri, S., Potla, R., Sarkar, J., Nurko, S., Harris, Z. L., and Fox, P. L. (2005). Unexpected role of ceruloplasmin in intestinal iron absorption. Cell Metab. 2, 309-319.
13. Chlosta, S., Fishman, D. S., Harrington, L., Johnson, E. E., Knutson, M. D., Wessling-Resnick, M., and Cherayil, B. J. (2006). The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect. Immun. 74, 3065-3067.
14. Chung, B., Chaston, T., Marks, J., Srai, S. K., and Sharp, P. A. (2009). Hepcidin decreases iron transporter expression in vivo in mouse duodenum and spleen and in vitro in THP-1 macrophages and intestinal Caco-2 cells. J. Nutr. 139, 1457-1462.
15. Cianetti, L., Segnalini, P., Calzolari, A., Morsilli, O., Felicetti, F., Ramoni, C., Gabbianelli, M., Testa, U., and Sposi, N. M. (2005). Expression of alternative transcripts of ferroportin-1 during human erythroid differentiation. Haematologica 90, 1595-1606.
16. Cohen, L. A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D. L., Crooks, D. R., Sougrat, R., Morgenstern, A., Galy, B., Hentze, M. W., et al. (2010). Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 116, 1574-1584.
17. Corna, G., Campana, L., Pignatti, E., Castiglioni, A., Tagliafico, E., Bosurgi, L., Campanella, A., Brunelli, S., Manfredi, A. A., Apostoli, P., et al. (2010). Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 95, 1814-1822.
18. De Domenico, I., McVey Ward, D., Nemeth, E., Ganz, T., Corradini, E., Ferrara, F., Musci, G., Pietrangelo, A., and Kaplan, J. (2006). Molecular and clinical correlates in iron overload associated with mutations in ferroportin. Haematologica 91, 1092-1095.
19. De Domenico, I., Ward, D. M., di Patti, M. C., Jeong, S. Y., David, S., Musci, G., and Kaplan, J. (2007a). Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 26, 2823-2831.
20. De Domenico, I., Ward, D. M., Langelier, C., Vaughn, M. B., Nemeth, E., Sundquist, W. I., Ganz, T., Musci, G., and Kaplan, J. (2007b). The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol. Biol. Cell 18, 2569-2578.
21. De Domenico, I., Ward, D. M., Musci, G., and Kaplan, J. (2007c). Evidence for the multimeric structure of ferroportin. Blood 109, 2205-2209.
22. De Domenico, I., Nemeth, E., Nelson, J. M., Phillips, J. D., Ajioka, R. S., Kay, M. S., Kushner, J. P., Ganz, T., Ward, D. M., and Kaplan, J. (2008). The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab. 8, 146-156.
23. De Domenico, I., Lo, E., Ward, D. M., and Kaplan, J. (2009). Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. Proc. Natl. Acad. Sci. USA 106, 3800-3805.
24. De Domenico, I., Zhang, T. Y., Koening, C. L., Branch, R. W., London, N., Lo, E., Daynes, R. A., Kushner, J. P., Li, D., Ward, D. M., and Kaplan, J. (2010). Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Invest. 120, 2395-2405.
25. De Domenico, I., Lo, E., Yang, B., Korolnek, T., Hamza, I., Ward, D. M., and Kaplan, J. (2011). The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin. Cell Metab. 14, 635-646.
26. Delaby, C., Pilard, N., Puy, H., and Canonne-Hergaux, F. (2008). Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression. Biochem. J. 411, 123-131.
27. Deschemin, J. C., and Vaulont, S. (2013). Role of hepcidin in the setting of hypoferremia during acute inflammation. PLoS ONE 8, e61050.
28. Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000). Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781.
29. Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., and Andrews, N. C. (2005). The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1, 191-200.
30. Drakesmith, H., and Prentice, A. M. (2012). Hepcidin and the iron-infection axis. Science 338, 768-772.
31. Drakesmith, H., Schimanski, L. M., Ormerod, E., Merryweather-Clarke, A. T., Viprakasit, V., Edwards, J. P., Sweetland, E., Bastin, J. M., Cowley, D., Chinthammitr, Y., et al. (2005). Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106, 1092-1097.
32. Duce, J. A., Tsatsanis, A., Cater, M. A., James, S. A., Robb, E., Wikhe, K., Leong, S. L., Perez, K., Johanssen, T., Greenough, M. A., et al. (2010). Ironexport ferroxidase activity of b-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867.
33. Fernandes, A., Preza, G. C., Phung, Y., De Domenico, I., Kaplan, J., Ganz, T., and Nemeth, E. (2009). The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 114, 437-443.
34. Finch, C. (1994). Regulators of iron balance in humans. Blood 84, 1697-1702.
35. Fuqua, B. K., Lu, Y., Darshan, D., Frazer, D. M., Wilkins, S. J., Wolkow, N., Bell, A. G., Hsu, J., Yu, C. C., Chen, H., et al. (2014). The multicopper ferroxidase hephaestin enhances intestinal iron absorption in mice. PLoS ONE 9, e98792.
36. Ganz, T. (2013). Systemic iron homeostasis. Physiol. Rev. 93, 1721-1741.
37. Gonçalves, A. S., Muzeau, F., Blaybel, R., Hetet, G., Driss, F., Delaby, C., Canonne-Hergaux, F., and Beaumont, C. (2006). Wild-type and mutant ferroportins do not form oligomers in transfected cells. Biochem. J. 396, 265-275.
38. Gordeuk, V. R., Caleffi, A., Corradini, E., Ferrara, F., Jones, R. A., Castro, O., Onyekwere, O., Kittles, R., Pignatti, E., Montosi, G., et al. (2003). Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol. Dis. 31, 299-304.
39. Guida, C., Altamura, S., Klein, F. A., Galy, B., Boutros, M., Ulmer, A. J., Hentze, M. W., and Muckenthaler, M. U. (2015). A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia. Blood 125, 2265-2275.
40. Hadziahmetovic, M., Dentchev, T., Song, Y., Haddad, N., He, X., Hahn, P., Pratico, D., Wen, R., Harris, Z. L., Lambris, J. D., et al. (2008). Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest. Ophthalmol. Vis. Sci. 49, 2728-2736.
41. Haldar, M., Kohyama, M., So, A. Y., Kc, W., Wu, X., Briseņo, C. G., Satpathy, A. T., Kretzer, N. M., Arase, H., Rajasekaran, N. S., et al. (2014). Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell 156, 1223-1234.
42. Harada, N., Kanayama, M., Maruyama, A., Yoshida, A., Tazumi, K., Hosoya, T., Mimura, J., Toki, T., Maher, J. M., Yamamoto, M., and Itoh, K. (2011). Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharideinduced ferroportin 1 mRNA suppression in macrophages. Arch. Biochem. Biophys. 508, 101-109.
43. Harris, Z. L., Durley, A. P., Man, T. K., and Gitlin, J. D. (1999). Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. USA 96, 10812-10817.
44. Haschka, D., Nairz, M., Demetz, E., Wienerroither, S., Decker, T., and Weiss, G. (2015). Contrasting regulation of macrophage iron homeostasis in response to infection with Listeria monocytogenes depending on localization of bacteria. Metallomics 7, 1036-1045.
45. Huang, Y. H., Yang, Y. L., Tiao, M. M., Kuo, H. C., Huang, L. T., and Chuang, J. H. (2012). Hepcidin protects against lipopolysaccharide-induced liver injury in a mouse model of obstructive jaundice. Peptides 35, 212-217.
46. Jeong, S. Y., and David, S. (2003). Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 278, 27144-27148.
47. Jiang, R., Hua, C., Wan, Y., Jiang, B., Hu, H., Zheng, J., Fuqua, B. K., Dunaief, J. L., Anderson, G. J., David, S., et al. (2015). Hephaestin and ceruloplasmin play distinct but interrelated roles in iron homeostasis in mouse brain. J. Nutr. 145, 1003-1009.
48. Johnson, E. E., Sandgren, A., Cherayil, B. J., Murray, M., and Wessling-Resnick, M. (2010). Role of ferroportin in macrophage-mediated immunity. Infect. Immun. 78, 5099-5106.
49. Kasvosve, I., Tshwenyego, U., Phuthego, T., Koto, G., Zachariah, M., Nyepetsi, N. G., and Motswaledi, M. S. (2015). Serum ferritin concentration is affected by ferroportin Q248H mutation in Africans. Clinica Chimica Acta 444, 257-259.
50. Kim, D. K., Jeong, J. H., Lee, J. M., Kim, K. S., Park, S. H., Kim, Y. D., Koh, M., Shin, M., Jung, Y. S., Kim, H. S., et al. (2014). Inverse agonist of estrogenrelated receptor g controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat. Med. 20, 419-424.
51. Kohyama, M., Ise, W., Edelson, B. T., Wilker, P. R., Hildner, K., Mejia, C., Frazier, W. A., Murphy, T. L., and Murphy, K. M. (2009). Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 457, 318-321.
52. Laftah, A. H., Ramesh, B., Simpson, R. J., Solanky, N., Bahram, S., Schümann, K., Debnam, E. S., and Srai, S. K. (2004). Effect of hepcidin on intestinal iron absorption in mice. Blood 103, 3940-3944.
53. Lakhal-Littleton, S., Wolna, M., Carr, C. A., Miller, J. J., Christian, H. C., Ball, V., Santos, A., Diaz, R., Biggs, D., Stillion, R., et al. (2015). Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc. Natl. Acad. Sci. USA 112, 3164-3169.
54. Lesbordes-Brion, J. C., Viatte, L., Bennoun, M., Lou, D. Q., Ramey, G., Houbron, C., Hamard, G., Kahn, A., and Vaulont, S. (2006). Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108, 1402-1405.
55. Liu, X. B., Nguyen, N. B., Marquess, K. D., Yang, F., and Haile, D. J. (2005a). Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells Mol. Dis. 35, 47-56.
56. Liu, X. B., Yang, F., and Haile, D. J. (2005b). Functional consequences of ferroportin 1 mutations. Blood Cells Mol. Dis. 35, 33-46.
57. Ludwiczek, S., Aigner, E., Theurl, I., and Weiss, G. (2003). Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101, 4148-4154.
58. Lymboussaki, A., Pignatti, E., Montosi, G., Garuti, C., Haile, D. J., and Pietrangelo, A. (2003). The role of the iron responsive element in the control of ferroportin1/ IREG1/MTP1 gene expression. J. Hepatol. 39, 710-715.
59. Mackenzie, B., and Garrick, M. D. (2005). Iron Imports. II. Iron uptake at the apical membrane in the intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G981-G986.
60. Marro, S., Chiabrando, D., Messana, E., Stolte, J., Turco, E., Tolosano, E., and Muckenthaler, M. U. (2010). Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter. Haematologica 95, 1261-1268.
61. Mayr, R., Janecke, A. R., Schranz, M., Griffiths, W. J., Vogel, W., Pietrangelo, A., and Zoller, H. (2010). Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J. Hepatol. 53, 941-949.
62. McCormack, W., Dorsky, R., Wright, S., Rainier, J., Davis, D., and Skliar, M. (2013). Consolidated Hearing Committee Report: Complaint-Research Misconduct (University of Utah).
63. McGregor, J. A., Shayeghi, M., Vulpe, C. D., Anderson, G. J., Pietrangelo, A., Simpson, R. J., and McKie, A. T. (2005). Impaired iron transport activity of ferroportin 1 in hereditary iron overload. J. Membr. Biol. 206, 3-7.
64. McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000). A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5, 299-309.
65. Mitchell, C. J., Shawki, A., Ganz, T., Nemeth, E., and Mackenzie, B. (2014). Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc. Am. J. Physiol. Cell Physiol. 306, C450-C459.
66. Mosser, D. M., and Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
67. Nairz, M., Fritsche, G., Brunner, P., Talasz, H., Hantke, K., and Weiss, G. (2008). Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur. J. Immunol. 38, 1923-1936.
68. Nairz, M., Schleicher, U., Schroll, A., Sonnweber, T., Theurl, I., Ludwiczek, S., Talasz, H., Brandacher, G., Moser, P. L., Muckenthaler, M. U., et al. (2013). Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J. Exp. Med. 210, 855-873.
69. Nekhai, S., Xu, M., Foster, A., Kasvosve, I., Diaz, S., Machado, R. F., Castro, O. L., Kato, G. J., Taylor, J. G., 6th, and Gordeuk, V. R. (2013). Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin. Haematologica 98, 455-463.
70. Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., and Kaplan, J. (2004). Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093.
71. Nemeth, E., Preza, G. C., Jung, C. L., Kaplan, J., Waring, A. J., and Ganz, T. (2006). The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 107, 328-333.
72. Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., and Vaulont, S. (2001). Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98, 8780-8785.
73. Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., and Vaulont, S. (2002). Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA 99, 4596-4601.
74. Osaki, S., and Johnson, D. A. (1969). Mobilization of liver iron by ferroxidase (ceruloplasmin). J. Biol. Chem. 244, 5757-5758.
75. Pagani, A., Nai, A., Corna, G., Bosurgi, L., Rovere-Querini, P., Camaschella, C., and Silvestri, L. (2011). Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood 118, 736-746.
76. Peyssonnaux, C., Zinkernagel, A. S., Datta, V., Lauth, X., Johnson, R. S., and Nizet, V. (2006). TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107, 3727-3732.
77. Pietrangelo, A. (2004). The ferroportin disease. Blood Cells Mol. Dis. 32, 131-138.
78. Pignatti, E., Mascheroni, L., Sabelli, M., Barelli, S., Biffo, S., and Pietrangelo, A. (2006). Ferroportin is a monomer in vivo in mice. Blood Cells Mol. Dis. 36, 26-32.
79. Portugal, S., Carret, C., Recker, M., Armitage, A. E., Gonçalves, L. A., Epiphanio, S., Sullivan, D., Roy, C., Newbold, C. I., Drakesmith, H., and Mota, M. M. (2011). Host-mediated regulation of superinfection in malaria. Nat. Med. 17, 732-737.
80. Preza, G. C., Ruchala, P., Pinon, R., Ramos, E., Qiao, B., Peralta, M., Sharma, S., Waring, A. J., Ganz, T., and Nemeth, E. (2011a). Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J. Clin. Invest. 121, 4880-4888.
81. Preza, G. C., Ruchala, P., Pinon, R., Ramos, E., Qiao, B., Peralta, M. A., Sharma, S., Waring, A., Ganz, T., and Nemeth, E. (2011b). Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J. Clin. Invest. 121, 4880-4888.
82. Qiao, B., Sugianto, P., Fung, E., Del-Castillo-Rueda, A., Moran-Jimenez, M. J., Ganz, T., and Nemeth, E. (2012). Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab. 15, 918-924.
83. Ramos, E., Ruchala, P., Goodnough, J. B., Kautz, L., Preza, G. C., Nemeth, E., and Ganz, T. (2012). Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood 120, 3829-3836.
84. Recalcati, S., Locati, M., Marini, A., Santambrogio, P., Zaninotto, F., De Pizzol, M., Zammataro, L., Girelli, D., and Cairo, G. (2010). Differential regulation of iron homeostasis during human macrophage polarized activation. Eur. J. Immunol. 40, 824-835.
85. Rice, A. E., Mendez, M. J., Hokanson, C. A., Rees, D. C., and Björkman, P. J. (2009). Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter. J. Mol. Biol. 386, 717-732.
86. Rivera, S., Nemeth, E., Gabayan, V., Lopez, M. A., Farshidi, D., and Ganz, T. (2005). Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106, 2196-2199.
87. Rivers, C. A., Barton, J. C., Gordeuk, V. R., Acton, R. T., Speechley, M. R., Snively, B. M., Leiendecker-Foster, C., Press, R. D., Adams, P. C., McLaren, G. D., et al. (2007). Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Mol. Dis. 38, 247-252.
88. Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., and Camaschella, C. (2003). Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33, 21-22.
89. Ross, S. L., Tran, L., Winters, A., Lee, K. J., Plewa, C., Foltz, I., King, C., Miranda, L. P., Allen, J., Beckman, H., et al. (2012). Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab. 15, 905-917.
90. Roy, C. N., Custodio, A. O., de Graaf, J., Schneider, S., Akpan, I., Montross, L. K., Sanchez, M., Gaudino, A., Hentze, M. W., Andrews, N. C., and Muckenthaler, M. U. (2004). An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice. Nat. Genet. 36, 481-485.
91. Sanchez, M., Galy, B., Muckenthaler, M. U., and Hentze, M. W. (2007). Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency. Nat. Struct. Mol. Biol. 14, 420-426.
92. Sangokoya, C., Doss, J. F., and Chi, J. T. (2013). Iron-responsive miR-485-3p regulates cellular iron homeostasis by targeting ferroportin. PLoS Genet. 9, e1003408.
93. Schimanski, L. M., Drakesmith, H., Merryweather-Clarke, A. T., Viprakasit, V., Edwards, J. P., Sweetland, E., Bastin, J. M., Cowley, D., Chinthammitr, Y., Robson, K. J., and Townsend, A. R. (2005). In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105, 4096-4102.
94. Schimanski, L. M., Drakesmith, H., Talbott, C., Horne, K., James, J. R., Davis, S. J., Sweetland, E., Bastin, J., Cowley, D., and Townsend, A. R. (2008). Ferroportin: lack of evidence for multimers. Blood Cells Mol. Dis. 40, 360-369.
95. Shah, Y. M., Matsubara, T., Ito, S., Yim, S. H., and Gonzalez, F. J. (2009). Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab. 9, 152-164.
96. Sham, R. L., Phatak, P. D., Nemeth, E., and Ganz, T. (2009). Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. Blood 114, 493-494.
97. Sierra-Filardi, E., Vega, M. A., Sánchez-Mateos, P., Corb?, A. L., and Puig-Krö-ger, A. (2010). Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 215, 788-795.
98. Taylor, M., Qu, A., Anderson, E. R., Matsubara, T., Martin, A., Gonzalez, F. J., and Shah, Y. M. (2011). Hypoxia-inducible factor-2a mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology 140, 2044-2055.
99. Torti, S. V., and Torti, F. M. (2011). Ironing out cancer. Cancer Res. 71, 1511-1514.
100. Vallelian, F., Schaer, C. A., Kaempfer, T., Gehrig, P., Duerst, E., Schoedon, G., and Schaer, D. J. (2010). Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity. Blood 116, 5347-5356.
101. Wang, L., Johnson, E. E., Shi, H. N., Walker, W. A., Wessling-Resnick, M., and Cherayil, B. J. (2008). Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J. Immunol. 181, 2723-2731.
102. Wong, B. X., Tsatsanis, A., Lim, L. Q., Adlard, P. A., Bush, A. I., and Duce, J. A. (2014). b-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS ONE 9, e114174.
103. Xu, M., Kashanchi, F., Foster, A., Rotimi, J., Turner, W., Gordeuk, V. R., and Nekhai, S. (2010). Hepcidin induces HIV-1 transcription inhibited by ferroportin. Retrovirology 7, 104.
104. Yanatori, I., Yasui, Y., Tabuchi, M., and Kishi, F. (2014). Chaperone protein involved in transmembrane transport of iron. Biochem. J. 462, 25-37.
105. Yang, F., Liu, X. B., Quinones, M., Melby, P. C., Ghio, A., and Haile, D. J. (2002). Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J. Biol. Chem. 277, 39786-39791.
106. Yeh, K. Y., Yeh, M., Mims, L., and Glass, J. (2009). Iron feeding induces ferroportin 1 and hephaestin migration and interaction in rat duodenal epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G55-G65.
107. Zhang, D. L., Hughes, R. M., Ollivierre-Wilson, H., Ghosh, M. C., and Rouault, T. A. (2009). A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab. 9, 461-473.
108. Zhang, D. L., Senecal, T., Ghosh, M. C., Ollivierre-Wilson, H., Tu, T., and Rouault, T. A. (2011a). Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts. Blood 118, 2868-2877.
109. Zhang, Z., Zhang, F., An, P., Guo, X., Shen, Y., Tao, Y., Wu, Q., Zhang, Y., Yu, Y., Ning, B., et al. (2011b). Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood 118, 1912-1922.
110. Zhang, Z., Zhang, F., Guo, X., An, P., Tao, Y., and Wang, F. (2012). Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice. Hepatology 56, 961-971.
111. Zohn, I. E., De Domenico, I., Pollock, A., Ward, D. M., Goodman, J. F., Liang, X., Sanchez, A. J., Niswander, L., and Kaplan, J. (2007). The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease. Blood 109, 4174-4180.